7 | VaccinesIBA
07/2004
-
10/2001 |
4 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2001
-
01/2000 |
4 | Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2000
-
01/2000 |
3 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2012
-
01/2000 |
3 | Phosphotransferases (Kinase)IBA
09/2000
-
02/2000 |
2 | Carbonic Anhydrase IIIIBA
01/2018
-
12/2011 |
2 | Biomarkers (Surrogate Marker)IBA
01/2018
-
12/2011 |
2 | CytokinesIBA
05/2012
-
07/2001 |
2 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
05/2012
-
11/2011 |
2 | Phenylalanine (L-Phenylalanine)FDA Link
02/2009
-
08/2007 |
2 | CatalaseIBA
08/2007
-
01/2001 |
2 | Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
08/2007
-
01/2001 |
2 | N-Acetylneuraminic Acid (Sialic Acid)IBA
07/2004
-
07/2003 |
2 | sialic acid receptorIBA
07/2004
-
07/2003 |
2 | vatalanib (PTK787)IBA
04/2000
-
01/2000 |
1 | MucinsIBA
01/2018 |
1 | InterleukinsIBA
01/2018 |
1 | Keratin-14 (Keratin 14)IBA
01/2018 |
1 | Messenger RNA (mRNA)IBA
01/2018 |
1 | setanaxibIBA
01/2017 |
1 | ChemokinesIBA
05/2012 |
1 | SB939 compoundIBA
05/2012 |
1 | 14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA
02/2012 |
1 | fms-Like Tyrosine Kinase 3IBA
11/2011 |
1 | GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA
02/2009 |
1 | Proteins (Proteins, Gene)FDA Link
02/2009 |
1 | EnzymesIBA
08/2007 |
1 | Calmodulin (Calcium-Dependent Activator Protein)IBA
08/2007 |
1 | CalciumIBA
08/2007 |
1 | Calcium-Transporting ATPases (Ca2+ ATPase)IBA
08/2007 |
1 | Silicon Dioxide (Silica)FDA LinkGeneric
04/2005 |
1 | bone mealIBA
04/2003 |
1 | Matrix Metalloproteinase 2 (Gelatinase A)IBA
07/2001 |
1 | CGS 27023AIBA
07/2001 |
1 | Matrix Metalloproteinase InhibitorsIBA
07/2001 |
1 | Biological ProductsIBA
07/2001 |
1 | Urokinase Plasminogen Activator ReceptorsIBA
07/2001 |
1 | CathepsinsIBA
07/2001 |
1 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2001 |
1 | Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
07/2001 |
1 | Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
07/2001 |
1 | Tissue Inhibitor of Metalloproteinase-1IBA
07/2001 |
1 | Tissue Inhibitor of Metalloproteinase-2IBA
07/2001 |
1 | Matrix Metalloproteinases (MMPs)IBA
07/2001 |
1 | sapropterin (tetrahydrobiopterin)FDA Link
01/2001 |
1 | primapterinIBA
01/2001 |
1 | Platelet-Derived Growth FactorIBA
09/2000 |
1 | Pharmaceutical PreparationsIBA
09/2000 |
1 | GenisteinIBA
09/2000 |
1 | Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2000 |
1 | Renin InhibitorsIBA
07/2000 |
1 | Tyrosine (L-Tyrosine)FDA Link
04/2000 |
1 | Retinaldehyde (Retinal)IBA
02/2000 |